Keyphrases
Common Variable Immunodeficiency
100%
X-linked
100%
SASH3
100%
CD4+
40%
Viral Infection
40%
Genetic Testing
40%
T Cell Depletion
40%
Combined Immunodeficiency
40%
B Cells
20%
CD8+
20%
T Cells
20%
Nave
20%
T Cell Proliferation
20%
CD8+ T Cells
20%
Adult Patients
20%
Number of Patients
20%
Mild Phenotype
20%
Clinical Spectrum
20%
Adaptor Protein
20%
Immunological Characteristics
20%
Haemophilus Influenzae
20%
Hemizygous
20%
Influenza B
20%
Influenza-like Illness
20%
T Cell Activation
20%
Thymocytes
20%
Lymphopenia
20%
Sinopulmonary Infections
20%
Gain-of-function mutation
20%
Streptococcus Pneumoniae
20%
Immune Dysregulation
20%
Targeted Gene Panel
20%
Memory B Cells
20%
Upper Respiratory Tract Infection
20%
Cutaneous Infection
20%
Polysaccharide Vaccine
20%
Mucosal Infection
20%
Conjugate Vaccine
20%
Suboptimal Response
20%
Varicella-zoster Virus Infection
20%
Immune Thrombocytopenia
20%
Normal Response
20%
Type A Influenza
20%
Inborn Errors of Immunity
20%
TCR Signaling
20%
Bilateral Pneumonia
20%
SARS-CoV-2 RNA
20%
RNA Vaccine
20%
Fault Test
20%
Immunology and Microbiology
Common Variable Immunodeficiency
100%
Viral Disease
100%
T Cell
100%
Genetic Screening
66%
T Cell Receptor
33%
Immunoglobulin M
33%
T Cell Proliferation
33%
Influenza
33%
B Cell
33%
T Cell Activation
33%
Memory B Cell
33%
Next Generation Sequencing
33%
Immune Dysregulation
33%
Thymocyte
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Cytotoxic T-Cell
33%
T-Helper Cell
33%
Pneumococcus
33%
X-Linked Severe Combined Immunodeficiency
33%
Combined Immunodeficiencies
33%
Primary Immunodeficiency
33%
CD4
33%
CD8
33%
Lymphocytopenia
33%
Varicella Zoster Virus
33%
Haemophilus Influenzae Type B
33%
Polysaccharide Vaccine
33%
RNA Vaccine
33%
Conjugate Vaccine
33%